Loading...
XTSENWH.UN
Market cap777mUSD
Jan 10, Last price  
4.53CAD
1D
-1.74%
1Q
-13.38%
Jan 2017
-55.59%
IPO
-61.08%
Name

NorthWest Healthcare Properties REIT

Chart & Performance

D1W1MN
XTSE:NWH.UN chart
P/E
—
P/S
2.21
EPS
—
Div Yield, %
13.27%
Shrs. gr., 5y
18.71%
Rev. gr., 5y
7.76%
Revenues
508m
+13.18%
64,973,645118,152,010134,458,000150,110,000150,429,000198,960,000277,346,000313,966,000349,592,000366,056,000373,818,000374,613,000448,829,000507,996,000
Net income
-348m
L
1,051,24178,341,04592,493,00036,520,000-22,195,000116,854,00056,963,00067,387,00065,715,00073,250,000314,355,000611,839,000125,627,000-347,690,000
CFO
105m
-53.27%
18,553,11032,261,59438,513,00038,625,00041,681,00046,590,000102,080,00090,840,00093,315,000115,816,000188,767,000124,967,000224,178,000104,765,000
Dividend
Sep 27, 20240.03 CAD/sh
Earnings
Mar 12, 2025

Profile

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at September 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 190 income-producing properties and 15.4 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages over 200 professionals across nine offices in 5 countries to serve as a long-term real estate partner to leading healthcare operators.
URL
https://www.nwhreit.com/
IPO date
Mar 23, 2010
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
507,996
13.18%
448,829
19.81%
Cost of revenue
178,941
151,777
Unusual Expense (Income)
NOPBT
329,055
297,052
NOPBT Margin
64.78%
66.18%
Operating Taxes
(18,289)
79,297
Tax Rate
26.69%
NOPAT
347,344
217,755
Net income
(347,690)
-376.76%
125,627
-79.47%
Dividends
(148,749)
(156,111)
Dividend yield
11.81%
6.84%
Proceeds from repurchase of equity
(209)
301,314
BB yield
0.02%
-13.19%
Debt
Debt current
452,546
506,804
Long-term debt
3,480,296
3,187,253
Deferred revenue
4,774,996
Other long-term liabilities
435,911
(4,734,914)
Net debt
3,421,698
2,986,490
Cash flow
Cash from operating activities
104,765
224,178
CAPEX
(98)
(615)
Cash from investing activities
194,266
(1,356,719)
Cash from financing activities
(318,503)
1,176,963
FCF
744,538
(232,638)
Balance
Cash
72,030
87,987
Long term investments
439,114
619,580
Excess cash
485,744
685,126
Stockholders' equity
3,045,544
4,789,922
Invested Capital
7,063,826
6,762,251
ROIC
5.02%
3.41%
ROCE
4.36%
3.76%
EV
Common stock shares outstanding
244,170
240,395
Price
5.16
-45.68%
9.50
-31.21%
Market cap
1,259,917
-44.83%
2,283,757
-24.41%
EV
5,772,571
7,643,046
EBITDA
330,321
298,448
EV/EBITDA
17.48
25.61
Interest
233,850
163,883
Interest/NOPBT
71.07%
55.17%